Goldman Sachs $413,361 Morgan Stanley $362,700 Citigroup Inc $350,895 Lehman Brothers $241,870 JP Morgan Chase & Co $214,880 EMILY’s List $213,266 National Amusements Inc $210,010 Kirkland & Ellis $179,676 Greenberg Traurig Llp $177,800 Skadden, Arps et al $167,796 Merrill Lynch $165,042 Cablevision Systems $145,313 Time Warner $144,977 Microsoft Corp $143,459 Bear Stearns $141,835 Latham & Watkins $138,598 Patton Boggs $137,200 Ernst & Young $126,865 PricewaterhouseCoopers $121,939
Goldman Sachs $421,763 Ubs Ag $296,670 Lehman Brothers $250,630 National Amusements Inc $245,843 JP Morgan Chase & Co $243,848 Sidley Austin LLP $226,491 Citigroup Inc $221,578 Exelon Corp $221,517 Skadden, Arps Et Al $196,420 Jones Day $181,996 Harvard University $172,324 Citadel Investment Group $171,798 Time Warner $155,383 Morgan Stanley $155,196 Google Inc $152,802 University of California $143,029 Jenner & Block $136,565 Kirkland & Ellis $134,738 Wilmerhale Llp $119,245 Credit Suisse Group $118,250
Less than two months after ascending to the United States Senate, Barack Obama bought more than $50,000 worth of stock in two speculative companies whose major investors included some of his biggest political donors.
One of the companies was a biotech concern that was starting to develop a drug to treat avian flu. In March 2005, two weeks after buying about $5,000 of its shares, Mr. Obama took the lead in a legislative push for more federal spending to battle the disease.
His wife, Michelle, a hospital vice president in Chicago, received a promotion that March, nearly tripling her salary to $317,000, and they bought a $1.6 million house in June.